Male Breast Cancer Terminated Phase 1 / 2 Trials for Romidepsin (DB06176)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01938833Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast CancerTreatment